Analysts Set Perrigo Company plc (NYSE:PRGO) PT at $35.00

Perrigo Company plc (NYSE:PRGO) has received an average recommendation of “Hold” from the five brokerages that are presently covering the company, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $35.00.

Several equities analysts have issued reports on PRGO shares. Piper Sandler cut shares of Perrigo from an “overweight” rating to a “neutral” rating and lowered their target price for the company from $34.00 to $27.00 in a research note on Monday, January 6th. Argus downgraded shares of Perrigo from a “buy” rating to a “hold” rating in a research report on Tuesday, January 14th. Finally, StockNews.com raised shares of Perrigo from a “hold” rating to a “buy” rating in a research report on Monday.

Insider Buying and Selling

In related news, Director Jeffrey B. Kindler sold 17,598 shares of the stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $28.27, for a total value of $497,495.46. Following the completion of the sale, the director now directly owns 5,409 shares of the company’s stock, valued at approximately $152,912.43. This represents a 76.49 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.70% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Perrigo

A number of hedge funds have recently made changes to their positions in the business. Versant Capital Management Inc purchased a new position in Perrigo during the 4th quarter valued at approximately $45,000. GAMMA Investing LLC grew its holdings in shares of Perrigo by 93.7% in the fourth quarter. GAMMA Investing LLC now owns 1,920 shares of the company’s stock valued at $49,000 after purchasing an additional 929 shares in the last quarter. Central Pacific Bank Trust Division raised its stake in Perrigo by 33.3% during the fourth quarter. Central Pacific Bank Trust Division now owns 2,000 shares of the company’s stock valued at $51,000 after purchasing an additional 500 shares in the last quarter. Venturi Wealth Management LLC bought a new position in Perrigo during the third quarter valued at $56,000. Finally, KBC Group NV grew its stake in shares of Perrigo by 25.1% in the 3rd quarter. KBC Group NV now owns 4,517 shares of the company’s stock worth $118,000 after buying an additional 905 shares in the last quarter. Institutional investors own 95.91% of the company’s stock.

Perrigo Stock Down 0.5 %

PRGO stock opened at $24.49 on Friday. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.56 and a quick ratio of 1.77. Perrigo has a 1-year low of $23.14 and a 1-year high of $33.46. The stock has a market capitalization of $3.34 billion, a P/E ratio of -20.93 and a beta of 0.54. The business has a fifty day moving average price of $25.57 and a 200-day moving average price of $26.46.

About Perrigo

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.